000 | 01040 a2200277 4500 | ||
---|---|---|---|
005 | 20250515160015.0 | ||
264 | 0 | _c20090511 | |
008 | 200905s 0 0 eng d | ||
022 | _a1873-4316 | ||
024 | 7 |
_a10.2174/138920109787315060 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPurow, Benjamin | |
245 | 0 | 0 |
_aNotch inhibitors as a new tool in the war on cancer: a pathway to watch. _h[electronic resource] |
260 |
_bCurrent pharmaceutical biotechnology _cFeb 2009 |
||
300 |
_a154-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aReceptors, Notch _xantagonists & inhibitors |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
773 | 0 |
_tCurrent pharmaceutical biotechnology _gvol. 10 _gno. 2 _gp. 154-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/138920109787315060 _zAvailable from publisher's website |
999 |
_c18644199 _d18644199 |